📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Characterisation of a cyclic peptide that blocks the RAS binding domain of phosphoinositide 3-kinase p110a (2022)

First Author: Ismail M

Attributed to: Cancer drug discovery targeting the interaction of RAS oncogenic proteins with phosphoinositide 3-kinase funded by UKRI Inn.Scholar

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21203/rs.3.rs-1854923/v1

Publication URI: http://dx.doi.org/10.21203/rs.3.rs-1854923/v1

Type: Preprint